BearDownAZ,
Why didn't the company run a phase 3 trial on CKD instead of the CVD trial BETonMACE,...?
In my mind (and I am probably totally wrong) the CKD would have been shorter in duration, less costly to run, would have given us access to a much bigger market, and it seems there was pretty good evidence of success from the Phase 2 trials as well as the Phase 1 trial in New Zealand,...
Thanks